‘Leading’ Swiss Fertility Firm Launches US Authorized Generics Unit
NJ-Based Yaral Pharma To Be Led By Former Alvogen, Mylan Exec
Executive Summary
With a mission to provide access “to high quality, affordable, authorized generics and complex generic medicines to enhance healthcare outcomes,” Yaral Pharma has launched in the US.
You may also be interested in...
Yaral To Expand Burgeoning Generics Portfolio With Support From Eversana
With three additional commercial launches lined up for 2023, Yaral has opted to expand its pre-existing partnership with life sciences service provider Eversana to support these activities.
Lannett Launches Authorized Tirosint In US
Lannett has launched levothyroxine sodium capsules, an authorized generic version of Tirosint, in partnership with IBSA in the US. The company faces the possibility of competition, as Teva may enter the market with certain generic strengths.
What’s Next? Five Things To Look Out For In December
Generics Bulletin previews the most noteworthy and anticipated events for December 2023.